Biotechnology Companies Worldwide
Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. No companies currently match this exact sector selection on Enterprise League. Browse related sectors or submit a company to the directory.
764 companies
Location
Category
Biotechnology
List of Biotechnology companies in All locations
764 companies
Sort by
Methinks vision is to provide universal and timely diagnosis for life-saving treatments worldwide. Our first focus is on stroke, the second cause of death and a major cause of disability in the world. Our product is an artificial intelligence medical imaging software capable of performing stroke triage and unlock stroke treatments potential from non-contrast CTs.
Methinks is a VC backed digital health start-up that recently won the prestigious EIC Accelerator of the European Commission and has obtained two gold medals in the RSNA Kaggle competitions. The recent funding of the company will allow us to grow rapidly and we are looking for exceptional and passionate individuals to help us face these challenges and build together a unique company.
Life Science
IT Consulting Services
Medical
IT Services
Medical Equipment and Services
Artificial Intelligence
Biotechnology
Metrion Biosciences is a UK-based Contract Research Organization specialising in high quality ion channel screening and drug development expertise. We aim to provide our customers with access to a range of in vitro screening services that includes cardiac safety (hERG, CiPA panel of human cardiac ion channels) and neurotoxicology testing and phenotypic assays on a fee-for-service or collaboration basis.
We pride ourselves on being able to provide a flexible and cost effective service with an unparalleled level of expertise. Collectively, our management team have amassed over 80 years of experience in ion channel drug discovery and our clients can access this high level of expertise as part of our dedicated service.
Life Science
Collaborative Consumption
Neuroscience
Medical
Healthcare
Market Research
Biotechnology
MiAlgae aims to revolutionize the current livestock and pet feed industries by producing microalgae rich in polyunsaturated fatty acids (PUFAs) to offer as a replacement to fishmeal in feed.
🚫🐟 Feed suppliers are in need of this alternative to fishmeal due to declining wild fish stocks and rising demand for Omega-3s. MiAlgae has developed an environmentally beneficial, effective, and simple solution of producing microalgae which delivers the required nutrients to livestock and pets without the need for fish.
♻️ Our zero-waste solution recycles the nutritional co-products from whisky production to grow Omega-3 rich microalgae, returning clean water in the process.
🌍 Our mission is to create a product that will contribute substantially towards the sustainable production of livestock, a prerequisite to fulfilling the needs of the growing world population.
💡Please check us out and follow us on:
-https://www.twitter.com/mialgae
-https://www.instagram.com/mialgae/
Manufacturing
Agriculture
Prediction Markets
Product Design
Market Research
Biotechnology
Micrima was founded in 2006 to develop and commercialise microwave radar breast imaging technology initially pioneered at the University of Bristol in the UK. The company's MARIA system is currently in clinical trials to collect valuable data for our machine learning algorithm's. The latest step in the journey to Breast Screening will be launched in 2022. This new system will provide density information and improved ergonomics for patient and operator. Contact us to arrange to see this system or to find out more.
Health and Medical Products
Medical
Healthcare
Medical Equipment and Services
Biotechnology
MicrobesNG is an innovative microbial genome sequencing service.
We provide value driven whole genome and metagenome sequencing and bioinformatics analysis to our global customer base for microbial applications (including bacterial, fungal and viral samples.)
Our journey so far has been amazing! Founded in 2014 within the University of Birmingham, with support of a BBSRC grant, we established our business and began to thrive. The next chapter in our evolution came in August 2019 when we “spun out” of the University after 5 years of successful operation. Since then it’s been onwards and upwards.
We are on a mission to deliver high value, quality sequencing data within academia and the public and private sectors. We consistently strive to ensure that our service offerings and capabilities match those required by our customers.
Providing a positive customer experience is at our core and we place our fantastic customers at the heart of everything we do. We enjoy a high percentage of repeat business demonstrating that we consistently deliver on our promises to our customers.
Our highly qualified and experienced teams excel at delivering quality sequencing data for both “high volume” and “single sample” projects.
Our service experience has made us specialists in coordinating projects involving multiple collaborators across different continents while incorporating the ability to deliver a personalised service. Our teams are always available to provide support and guidance for those customers that are new to microbial genome sequencing.
MicrobesNG really is a sequencing service for all users!
Biotechnology
Microbiotica identifies gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers from clinical datasets.
Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products.
Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair.
It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche in IBD, and University of Adelaide in Ulcerative Colitis.
Therapeutics
Healthcare
Biotechnology
We brings precise microencapsulation at industrial scale:
Microcaps developed a novel technology that enables the scalable production of precise microcapsules and microparticles based on microfluidics. With this invention, microcaps is able to increase the controlled production by a factor of 1000 compared to state-of-the-art technologies. Our goal is to provide an upscalable, fully-automated encapsulation micro-factory, that enables size control, precise dosing and increased stability of the microcapsules and microparticles.
IT Consulting Services
Medical
IT Services
Computer Hardware
Chemicals
Chemical Engineering
Biotechnology
Pushing boundaries to drive Impact!
Championing the future of protein through microorganisms
Building Smaller, Better, Faster
Hamburg & Lisbon
Join us, we are hiring!
Biotechnology
MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.
Neuroscience
Healthcare
Therapeutics
AR and VR Development
Biotechnology
Health technology company helping bipolar psychiatric patients to manage their diagnosis through continuous monitoring and data analytics.
Personal Health
Healthcare
Biotechnology
Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million
Medical
Genetics
Healthcare
Pharmaceutical
Biotechnology
Our mission at MiroBio is to deliver transformational immunotherapies for people suffering from autoimmune disease. Immune imbalance is at the heart of many conditions which are marked by an attack on the body’s own cells. MiroBio is advancing a new class of therapies designed to restore immune balance – or homeostasis – and potentially provide durable remission from these chronic, complex conditions.
To achieve this, MiroBio has built deep expertise in an emerging area of immunology: precise activation of inhibitory pathways to restore healthy immune function. Our pipeline of agonistic antibodies and supporting platform are informed by over a decade of foundational research.
MiroBio draws upon a transatlantic team of advisers, drug developers and leading healthcare investors to further its leadership in this vast new area of immunology.
Life Science
Biotechnology
Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need.
Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’.
Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas.
Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially with a patient selection strategy to enhance the probability of demonstrating early signs of efficacy.
Mission’s leadership team has a wealth of international, commercial and scientific experience, and the company has strong links with key academic and research centers including Cancer Research UK Laboratories and the Jackson Laboratories at the Gurdon Institute, University of Cambridge.
The Company has to date received £87 million in venture capital from a blue chip syndicate comprising institutional and corporate investors and was awarded a £1.9 million grant from Innovate UK in September 2015.
In February 2016, the Company raised £60 million in a Series C financing led by Imperial Innovations and new investor Woodford Patient Capital Trust. It included follow-on investment from existing shareholders Sofinnova Partners, SR One, Roche Venture Fund and Pfizer Venture Investments. Mission is based at the Babraham Research Campus, south of Cambridge.
Therapeutics
Life Science
Healthcare
Biotechnology
Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune based therapies, including powerful cell therapies, that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a global team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.
Biotechnology
At Mycorena, we are on a mission to significantly change how we produce and consume food. We believe in the power of fungi and want to pave the way for a sustainability revolution by offering the industry scalable, high-quality products. Through innovative technology, we develop sustainable mycelium-based solutions for the food industry. Our flagship product Promyc is a proprietary vegan mycoprotein with superior nutritional value in protein, fibre, vitamins, and minerals. With a neutral taste and a satisfying fibrous texture, Promyc offers the most demanded qualities in the alternative protein segment.
What originated as a research project has grown into one of the fastest-growing companies in the industry. Since our founding in 2017, we have scaled from a small lab to Scandinavia’s largest demo production facility for mycoprotein. We are expanding further as we prepare to commence commercial production in our new Promyc Production Plant, the first of its kind in Scandinavia. Our vision is to be world-leading in fungi-based technology and drive the change in the food system for a sustainable tomorrow. The future of food is now.
Food Vendors
Manufacturing
Food Processing
Biotechnology
Food Manufacturing
#Nanolive: Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics.
Nanolive delivers breakthrough 3D imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.
3D Technology
Biotechnology
Nanomik, develops & produces microencapsulated biopesticides for food and agricultural products that protects them against food spoilage without changing their quality.
Today whole World suffers from the food waste. Approximately 30% of fresh fruits and vegetables are lost before coming to the stall. Economic impact of mentioned losses is beyond 1.3 Billion $ annually. In traditional preservation, very harmful chemicals and their synthetic derivatives are used for protection; however, their usage is limited because of their negative effects to the human. Amounts allowed for usage are not sufficient for the long-term protection. These chemicals and harmful microorganism toxins are the main problems for the export of agricultural products because of their harmful effects to human and nature.
Our company Nanomik aims to show that all food and agricultural products can be protected naturally without harmful chemicals and food waste can be decreased to the minimal levels.
Mainly, the World with more natural products and healthy foods is aimed by Nanomik!
Life Science
AgTech
Biotechnology
Who we are:
A collective of entrepreneurs, scientists, and experts dedicated to a sustainable future.
What we do:
We rear Black Soldier Fly to produce protein, oil, and fertilizer for the feed and agriculture industries.
Where we do it:
We chose Bulgaria as home to our first industrial-scale production facility; it’s close to vital markets such as Greece, Turkey and Western Europe, as well as offering advantageous labor and business conditions.
Agriculture
AgTech
Farming Services
Animal Feed
Biotechnology
Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey.
At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development.
Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners.
This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Life Science
Personal Health
Health and Medical Products
Healthcare
Health Centers
Medical Equipment and Services
Bioinformatics
Navinci (formerly Olink Bioscience), has a proud history of inventing analytic technologies for nucleic acids and proteins, identifying commercial opportunities and bringing successful products to the market to serve scientist in research and drug development. Founded in 2004 on the breakthrough innovations by Ulf Landegren and colleagues at Uppsala University, the company has directly marketed a wide range of products including the Duolink in situ protein detection product line, which was acquired by Sigma-Aldrich in 2016.
Navinci has also launched several daughter companies such as Olink Proteomics (noted Nasdaq NY: OLK) for high-throughput protein analysis in blood, Q-linea (noted on Nasdaq) focusing on counteracting antibiotic resistance in sepsis, and Halogenomics (acquired by Agilent) in target selection for next generation sequencing. Moreover, the company has outlicensed IP rights to several leading international life science companies. Navinci holds a broad and growing patent portfolio utilizing oligonucleotide-conjugated antibodies for detection of proteins and their interactions.
From our base in Uppsala, Sweden, Navinci contributes to improve human health by serving scientist with sharp and tailored tools to study proteins and their interactions in order to understand human biology and develop better drugs.
Health Centers
Healthcare
Health and Medical Products
Biotechnology
Our immersive platform helps people understand the relationship between their cognitions, emotions, and actions and utilize the influence that one exerts on the other. With a data-driven algorithm combined with virtual reality technology, we continuously track user behavior over the course of their health-activating journey and generate the most personalized program to enhance their mental, physio-physical, or social and emotional skills.
IT Consulting Services
IT Services
Healthcare
AR and VR Development
Skill Assessment
Biotechnology
NeoPhore is creating novel small molecule immuno-oncology therapeutics. NeoPhore's drugs target genetic mechanisms that both clinical and lab validation studies suggest will promote neoantigen creation and diversity across numerous cancers. Alone or in combination with other cancer immunotherapies, drugs that spark cancer neoantigen creation are designed to stimulate the immune system and improve outcomes for patients who fail to benefit from the current generation of cancer immunity therapeutics.
Therapeutics
Legal Translation Services
Biotechnology
We are a biotechnology-based company focused on the exploitation of marine biodiversity applied to human needs. The company was born with the objective of developing and bringing innovative solutions to the world for problems in different markets, using one of the richest and most diverse groups of organisms on the planet: microalgae.
Research and development are the soul and engine of our company and therefore we constantly collaborate in research and development projects with the most recognized research centers and universities in the world. The founders of NEPTUNUS BIOTECH have more than 25 years of experience giving sustainable and innovative solutions to the agricultural industry. In addition to having a world-class and personal scientific council with more than 30 years working with microalgae, plants and other photosynthetic organisms.
The technological platform of NEPTUNUS BIOTECH provides solutions to three different markets: agricultural, food and personal care.
Biotechnology
Netabolics, part of Microsoft for Startups Founders Hub, develops an insilico target selection platform that integrates the predictive power of artificial intelligence and machine learning (AI/ML) with the explainable nature of biosimulation based on first principles of physics and biology.
Artificial Intelligence
Life Science
Biotechnology
Mission
NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease.
Vision
A future in which patients with neuromuscular disease live better and more independent lives.
We have a unique translational muscle electrophysiology platform leveraging in-depth know-how of muscle physiology and muscular disorders for discovering and developing first-in-class therapeutics in neuromuscular diseases with a significant unmet medical need.
NMD Pharma is the leading company utilizing ClC-1 Cl- ion channel inhibitors for neuromuscular diseases and currently has one clinical-stage product candidate for the treatment of myasthenia gravis.
We have more than 25 employees with expertise in all areas of drug development. We are headquartered in Aarhus, Denmark, and collaborate with internationally renowned companies and key opinion leaders in the field of neuromuscular diseases.
For more information, please visit the company website.
Medical
Pharmaceutical
Biotechnology
Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations.
Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials.
Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed with Jinkō®.
IT Consulting Services
Medical
IT Services
CRM
Healthcare
Artificial Intelligence
Biotechnology
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. The dark genome holds more than 90% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. The Company has the unique ability to link these variants to gene function and precisely map disease pathways. Nucleome’s cell type-specific platform creates high resolution 3D genome structure maps and enables variant functional validation at scale in primary cell types, enabling the discovery and development of novel, better and safer drugs. The initial focus of the company is on lymphocytes and related autoimmune disease. Nucleome’s ambition is to build a robust pipeline of drug assets, with corresponding biomarkers. Nucleome Therapeutics was founded by leading experts in gene regulation from the University of Oxford. For more information, please visit www.nucleome.com.
Therapeutics
Genetics
Biotechnology
We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.
Manufacturing
Pharmaceutical
Biotechnology
Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy.
We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin.
By translating nature’s wisdom into innovation, together, we can change the life of billions.
Data Analysis
Big Data and BI
Artificial Intelligence
Bioinformatics
Biotechnology
The North West Biotech Initiative (NWBI) provides a platform that encourages knowledge sharing and dialogue between young students, local and international businesses and industry experts. We promote the development of early stage researchers in the STEM fields by providing an inclusive space for fostering relationships between academia and the growing local biotech sector.
This provides students the power of choice; to choose a career path based on interest and passion and not due to a lack of skills or opportunities. Thus, students will be prepared to apply in-demand professional skills in any arena and sector they choose to pursue in life beyond their academic institutions.
Biotechnology
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
Biopharma
Therapeutics
Healthcare
Biotechnology
Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients.
Radspherin®, the company’s lead product candidate is a novel alpha-emitting radioactive microsphere suspension designed for treatment of metastatic cancers in body cavities. Radspherin® has shown strong and consistent anticancer activity at essentially non-toxic doses in preclinical studies and is anticipated to potentially treat several forms of metastatic cancer.
Situated in Oslo, Oncoinvent’s main offices include modern laboratory facilities suitable for cGMP and radiopharmaceutical manufacture for clinical trials and research. The development programs of the company include radiotherapeutic and radioimmunotherapeutic products with focus on alpha-emitting radionuclides for treatment of various solid cancers.
Oncoinvent – Innovations for better cancer care.
Life Science
Pharmaceutical
Biotechnology
See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells and tissue.
We believe that understanding science at a molecular level will fundamentally allow you to unlock new discoveries, so we created our flagship product, The Nanoimager. We built the world's first desktop compatible compact super-resolution microscope, but we did it our way.
Our teams have a restless enthusiasm to bring technologies like super-resolution to a new community of researchers and we continue working until barriers of accessibility and affordability are addressed. Our mission is to ensure research and collaboration tools are available to those willing to ask why or how things are the way they are and answer questions never asked before.
We can’t wait to see and hear about what new questions you will ask!
Life Science
Nanotechnology
Software
Biotechnology
Our mission is to help life sciences companies accelerate drug development for improved patient outcomes, and we do this by championing the power of data.
Our main product DISQOVER is an optimized search or knowledge platform which draws on semantic technology and an ontology-based knowledge graph to find links between data across databases (internal data, public data and third party data) faster and more efficiently.
The platform has been developed for the pharmaceutical and biotech industries.
There are thousands of health research databases, clinical trials, literature reviews, patient studies, etc. available. Before setting up a new study, scientists first need to check what kind of research has already been done – both internally and externally – on, for instance, growth hormone applications for a particular disease. In many companies, even internal information resides in hundreds of different databases, each with their own interface and search logic. As a consequence, just finding this kind of background information is a very time-consuming process. This is where DISQOVER comes in.
One of the assets is that we use semantic technology to find logical but often hidden connections between internal and external data, allowing you to easily combine information from a multitude of different sources. As such, pharma and biotech companies can save valuable time and money that they can now invest in developing new medicines or treatments.
Customers include: AstraZeneca, AmGen, Medidata, Prinses Máxima Institute, Aelin Therapeutics and more.
DISQOVER is used amongst others by scientific researchers, bioinformaticians, and data scientists.
Try DISQOVER: our community edition is always up-to-date and accessible via www.ontoforce.com (choose “try now” top right corner)
Life Science
IT Consulting Services
Data Integration
IT Services
Software
Data Visualization
Pharmaceutical
With so much potential for biotech to make the world a better place to live, we knew we needed to make the lab a better place to work.
We’re a team of scientists and designers who have meticulously studied the in-lab experience, getting a detailed understanding of workflows and identifying common pain points that routinely cost scientists time and money.
Our BioHotel labs are designed with biotech startups in mind:
- Short term, flexible leases
- Central London locations in key life sciences clusters
- BSL2 lab spaces that can be tailored to your workflow
- Specialist services including cryogenic freezer storage, glassware washing and sterilisation and a lab coat laundry
- Access to bookable specialist labs and equipment
- All-inclusive clinical, chemical and general waste services
- Discounts and free delivery from our store
Biotechnology
We are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE® (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery System™ (EDS®) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis).
In September 2017, the U.S. Food and Drug Administration (FDA) approved XHANCE for the treatment of nasal polyps in patients 18 years of age or older. XHANCE was made widely available through commercial channels in April 2018.
In March and June 2022, we announced positive top line results from our two Phase 3b clinical trials (ReOpen1 and ReOpen2) of XHANCE for a follow-on indication for the treatment of chronic sinusitis. In February 2023, we submitted a prior approval efficacy supplement (sNDA) to support the approval of a new indication for XHANCE for the treatment of chronic rhinosinusitis. If the sNDA is approved, XHANCE has the potential to be the first drug therapy approved by the FDA for the treatment of chronic sinusitis.
As of February 20, 2023, we had a total of 141 full-time employees all of whom are in the United States, and no part-time employees.
Culture is a critical element in the management of our organization. Our colleagues are focused on driving our business with the Optinose values as the foundation for all our efforts. Our goal is that each colleague feels a deep connection to what they do, loves coming to work and is aligned to our One Mission – to improve lives. Our values of Authenticity, Fearless Conversations, Friendship, Openness, Perseverance and Possibility Thinking guide our actions and decisions.
Medical Equipment and Services
Pharmaceutical
Health and Medical Products
Biotechnology
Manufacturing
Ori Biotech is a London- and New Jersey-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.
By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.
So complex manufacturing challenges can be put where they belong – in the past.
Manufacturing
Industrial Automation
Biotechnology
Therapeutics
Industrial Machinery and Equipment
Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology.
Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both compounds are under preparation. Our pipeline also includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases, and additional programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurological diseases.
Oryzon has been listed on the Spanish Stock Exchange since December 2015 (ORY, ISIN Code: ES0167733015). Since then, the company has attracted specialized investors from US, Israel and Europe in several PIPEs led by different US investment banks.
The company was founded in 2000 and has offices in Spain and the United States.
Medical
Genetics
Healthcare
Biopharma
Therapeutics
Biotechnology
Osivax’ mission is to develop “universal” vaccines against highly-mutating viruses. Leveraging its unique oligoDOM® technology platform, OSIVAX is developing a universal vaccine for both current and future influenza infections. The Company’s universal flu vaccine candidate, OVX836 is in Phase 2a clinical development. OSIVAX is leveraging the same platform technology for the development of a universal vaccine against all existing and emerging coronavirus infections. OSIVAX is focused on providing proof-of-concept in influenza and coronavirus, and to applying its oligoDOM® platform broadly in other infectious and immune system-associated diseases.
Clinical Trials
Healthcare
Biotechnology
We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications.
Our microscopes are easy-to-use, label-free and non-invasive tools for the three-dimensional, real-time imaging of living cells. Based on patented differential digital holography technology, our advanced systems generate reliable, high-quality holographic images providing highly-reproducible tracking of:
- cell density
- morphology
- cell viability
- viral infection kinetics
- cell activation status
Direct Benefits
Our technology can benefit a range of applications, from R&D to manufacturing
processes, and enable significant cost reduction and quality improvement. Our
microscopes are particularly convenient and robust for automated cell culture
monitoring, analysis and quality control.
Life Science
3D Technology
Health and Medical Products
Software
Medical Equipment and Services
Biotechnology
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
Health and Medical Products
Genetics
Biopharma
Health Centers
Nanotechnology
Biotechnology
PathoQuest helps biopharmaceutical developers and manufacturers get their therapies to market with our leading expertise in GMP NGS-based biosafety testing and characterization services.
As innovator companies continue to bring exciting novel therapies to market, there is a critical need for alternative biosafety and characterization strategies. This is especially the case for life-changing cell and gene therapies, as well as novel viral vaccines. Classical testing approaches, such as cell based assays, are often challenging to implement due to high volume requirements, as well as compatibility issues.
Biosafety testing and characterization are key regulatory requirements for the release of biologic therapies. Therefore, alternative methods which can address these issues are of intense interest. There is also a drive from across industry and regulators to reduce, and eventually eliminate the use of animal models used in biosafety testing.
The genomic approach of Next Generation Sequencing (NGS) can solve many of the challenges that are faced by developers and manufacturers, such as lower volume requirements and incompatibility with cell-based assays
From our origins within the Institut Pasteur, PathoQuest is leading the way in expertise for the provision of GMP NGS based biosafety testing. Our expertise is underlined with over 20 peer reviewed publications on NGS applications in biosafety testing; as well as active participation in industry groups such as PDA, ADVTIG, CAACB and EFPIA. PathoQuest are committed to bringing this game-changing genomic approach to biopharmaceutical developers and manufacturers.
PathoQuest has a global footprint, with operations in Europe (Paris) and North America (Wayne, PA); and have provided NGS biosafety testing services to over 100 of the top biopharmaceutical companies globally.
Why not get in touch to see how we can help you with your biosafety testing strategy?
Therapeutics
Healthcare
Biotechnology
biomodal is an omics based life-sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Our duet multiomics solution enables more epigenetic information from a single, low input DNA library without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, phased sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing.
Biotechnology
CopperTree Forensics Ltd produce compact, practical Forensic Laser and LED Systems, which detect latent fingerprints, sweat, urine, saliva, blood, and other biological traces during fluorescent examination.
Our development programme is in collaboration with UK Law Enforcement and Forensic Services, to achieve first class products that meet the Laser and LED requirements in the field and the Lab. We will continue to develop innovative and ground breaking products to meet the needs of those involved in criminal investigation.
CopperTree Forensics also work very closely with UK Universities and the Home Office for testing and ongoing research for “in the field scenarios” using our range of wavelength capabilities.
It’s a constant challenge for law enforcement agencies to stay ahead of criminal activity and technological developments. Coupled with greater forensic awareness and the challenge of budget cuts shrinking resources, it has never been more important for companies like CopperTree Forensics to provide the support and products required for the fight against crime.
In addition, we offer a full range of services to further assist our customers. Our technically trained team can advise and support your ongoing requirements. We are dedicated to adding value by combining superior technology with unparalleled support. Whilst also providing bespoke systems and OEM for partners worldwide.
The commitment to customer care and attention to detail means we are constantly looking to develop and supply the best equipment possible to assist customers in the never ending fight against crime.
Biotechnology
SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.
Medical
Therapeutics
Biotechnology
Healthcare
Our company has the purpose of bridging the gap between insects & food companies so we can create the future of food Now!
“We believe in a greener and healthier future, and we know is possible by changing the base of production without waiting for consumer behavior to change. There is an urgent need for better, safer and more sustainable sources of food ingredients and materials for the food industry.
We can do this using biotechnology & data science to unlock the potential of insects as ingredients, biomaterials & many more to be discovered.”
Alejandro Ortega, CEO & Founder
Daniela Arias, COO & Founder
Inspired by their culture Daniela and Alejandro named the company after the primary deity in the Talamancan mythology of Costa Rica, is the creator of Earth and humanity, god of wisdom and taught the values using natural resources in a responsible way and with harmony.
We help insect ingredient manufacturers meeting the requirements of food companies & food brands, which requires improving the qualify and functionality of their current materials using new and innovative process optimization technologies we develop.
Together with this we focus on accelerating the innovation & development using data science for targeted ingredient discovery, to create clean, efficient, and sustainable insect-based bio-active components including protein, fats and chitosan, as highly functional food ingredients for food manufacturers.
And we can do it thanks to our unique green Isolation technology called Entowise®, which unlocks the potential of insect-bioactive components and improves the application of these materials as ingredients for food production. The Entowise® technology helps insect manufacturers to develop high value added and easy to use ingredients for food manufactures.
Our technology and approach help food manufacturer reduce CO2 emissions up to 95% compared with current alternatives, while also improve the health of their end consumer
Food Vendors
Dietary Supplements
Advanced Materials
Biotechnology
Enara Bio’s purpose is to shine a light on unconventional T cell targets to develop the next generation of cancer immunotherapies designed to treat broad patient populations. Enara’s proprietary EDAPT™ platform enables the discovery of Dark Antigens™, a novel source of shared, tumor-specific T cell targets derived from genomic dark matter. We are pioneering approaches to exploit these Dark Antigen targets with a range of immunotherapeutic modalities, including bispecific T-cell engagers, adoptive cell therapies and cancer vaccines. Based in Oxford, UK, Enara Bio is backed by RA Capital, Samsara Biocapital and SV Health Investors. For more information, please visit: www.enarabio.com
Comments and DMs to this account are not monitored, for any further information please head to our website
Biotechnology
Unicorn Bio is building next-gen cell culture manufacturing systems to make the development and manufacture of living cell based products faster and more efficient.
We enable our partners to seamlessly scale their innovations - from iPSC based cell therapies to cultivated meat - from the lab bench to commercial scale manufacturing.
So that scale-up stresses are a thing of the past, and you can focus on creating transformative technologies to actively improving human and planetary health.
Biotechnology
reNEW Technologies - a circular enterprise - has developed a patented biothermal 2-step process to ferment and extract volatile fatty acids (VFA) and nutrients (NPK) from biosolids.
This project was incubated within UTB Envirotec and is funded by the European Union's Horizon 2020 initiative.
Biotechnology
Siamo una società diversa, una società biotech, un modo di vivere, un'intera filosofia basata sul metodo scientifico e in cui le persone sono l'inizio e la fine del nostro entusiasmante progetto. Lavoriamo quotidianamente per loro sullo sviluppo delle migliori soluzioni tecnologiche, utilizzando l'estrazione di fitocomplessi dalla canapa per uso farmaceutico e cosmetico, l’estrazione di cellulose, nanocellulose e microfibrille di cellulosa per il mercato delle bioplastiche e l'estrazione dei derivati del carbonio per l'applicazione in diversi campi tra cui quello dell'ediliza e dell'automotive, il tutto per cercare di dare un apporto nel raggiungimento di una maggiore ecosostenibilità e una migliore qualità di vita.
Professionisti in diversi settori (farmaceutico, edile, alimentare, ecc.) ci accompagnano lungo il nostro percorso e si fidano di noi, aiutandoci a ottenere e trasferire le tecniche più innovative in soluzioni per i nostri clienti. La nostra filosofia di lavoro è un modo di vivere che inizia con l'analisi delle esigenze specifiche dei diversi campi che trattiamo, prosegue con lo sviluppo delle soluzioni per venire incontro a tali esigenze e si conclude con i risultati prodotti per rivalutarle e migliorarle. Durante questo processo, effettuiamo ricerche seguendo un rigoroso metodo scientifico, pubblichiamo su importanti riviste scientifiche, testiamo, omologhiamo, produciamo e commercializziamo tutte le nostre innovazioni in Italia e all'estero, sempre con una chiara vocazione multidisciplinare. Ci comportiamo responsabilmente in ogni situazione e fissiamo standard elevati ai quali non veniamo mai meno. Questa condotta etica senza compromessi consente di mantenere l’efficienza dei nostri processi, l'integrità dei nostri prodotti, la sicurezza dei nostri collaboratori e il rispetto dell'ambiente in cui viviamo.
Biotechnology
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Barcelona, Spain | Science and Engineering +3 Science and Engineering, Business Services, Health and Medical, Information Technology | 10-20 | p.rodriguez@methinks.ai | https://www.methinks.ai/ | ||
Cambridge, United Kingdom (UK) | Science and Engineering +4 Science and Engineering, Other, Health and Medical, Sport and Recreation, Sales and Marketing | 30-50 | info@metrionbiosciences.com | https://www.metrionbiosciences.com/ | ||
Edinburgh, United Kingdom (UK) | Manufacturing and Industry +5 Manufacturing and Industry, Agriculture and Livestock, Finance and Banking, Design Services, Sales and Marketing, Science and Engineering | 30-50 | info@mialgae.com | https://www.mialgae.com/ | ||
Bristol, United Kingdom (UK) | Health and Medical +2 Health and Medical, Sport and Recreation, Science and Engineering | 10-20 | info@micrima.com | https://www.micrima.com/ | ||
Birmingham, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@microbesng.com | https://microbesng.com/ | ||
Cambridge, United Kingdom (UK) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | info@microbiotica.com | https://microbiotica.com/ | ||
Schlieren, Switzerland | Business Services +5 Business Services, Health and Medical, Information Technology, Electronics, Manufacturing and Industry, Science and Engineering | 20-30 | info@microcaps.ch | https://microcaps.ch/ | ||
Hamburg, Germany | Science and Engineering Science and Engineering | 20-30 | hello@microharvest.com | https://microharvest.com/ | ||
Lausanne, Switzerland | Science and Engineering +3 Science and Engineering, Sport and Recreation, Health and Medical, Information Technology | 150-200 | info@mindmaze.com | https://mindmaze.com/ | ||
Prague, Central African Republic | Health and Medical +2 Health and Medical, Sport and Recreation, Science and Engineering | 10-20 | info@mindpax.me | https://mindpax.me/ | ||
Barcelona, Spain | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@minoryx.com | https://www.minoryx.com/ | ||
Oxford, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@mirobio.com | http://www.mirobio.com/ | ||
Cambridge, United Kingdom (UK) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | info@missiontherapeutics.com | http://missiontherapeutics.com/ | ||
Paris, France | Science and Engineering Science and Engineering | 30-50 | media@mnemo-tx.com | https://www.mnemo-tx.com/ | ||
Gothenburg, Sweden | Food and Beverages +2 Food and Beverages, Manufacturing and Industry, Science and Engineering | 50-100 | info@mycorena.com | https://mycorena.com/ | ||
Ecublens, Switzerland | Design Services +1 Design Services, Science and Engineering | 50-100 | lookinginsidelife@nanolive.ch | https://www.nanolive.ch/ | ||
Istanbul, Turkey | Science and Engineering +1 Science and Engineering, Agriculture and Livestock | 10-20 | info@nanomik-tech.com | https://nanomik-tech.com/ | ||
Sofia, Bulgaria | Agriculture and Livestock +2 Agriculture and Livestock, Pets and Animals, Science and Engineering | 50-100 | xavier.marcenac@nasekomo.life | https://nasekomo.life/ | ||
Zurich, Switzerland | Science and Engineering +2 Science and Engineering, Health and Medical, Sport and Recreation | 2-10 | info@navignostics.com | https://www.navignostics.com/ | ||
Uppsala, Sweden | Health and Medical +2 Health and Medical, Sport and Recreation, Science and Engineering | 20-30 | contact@navinci.se | https://navinci.se/ | ||
Istanbul, Turkey | Business Services +4 Business Services, Information Technology, Sport and Recreation, Education and Training, Science and Engineering | 50-100 | korhan@neoauvra.com | https://www.neoauvra.com/ | ||
Cambridge, United Kingdom (UK) | Health and Medical +2 Health and Medical, Legal, Science and Engineering | 10-20 | info@neophore.com | https://www.neophore.com/ | ||
Manchester, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@neptunusbiotech.com | https://neptunusbiotech.com/ | ||
Rome, Italy | Information Technology +1 Information Technology, Science and Engineering | 2-10 | info@netabolics.ai | https://netabolics.ai/ | ||
Aarhus, Denmark | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | contact@nmdpharma.com | https://www.nmdpharma.com/ | ||
Lyon, France | Business Services +4 Business Services, Health and Medical, Information Technology, Sport and Recreation, Science and Engineering | 50-100 | contact@novadiscovery.com | https://www.novadiscovery.com/ | ||
Oxford, United Kingdom (UK) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@nucleome.com | https://nucleome.com/ | ||
Düsseldorf, Germany | Manufacturing and Industry +2 Manufacturing and Industry, Health and Medical, Science and Engineering | 10-20 | info@numaferm.com | https://numaferm.com/ | ||
Dublin, Ireland | Information Technology +1 Information Technology, Science and Engineering | 50-100 | info@nuritas.com | https://www.nuritas.com/ | ||
Manchester, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | manchester@nwbiotech.co.uk | https://www.nwbiotech.co.uk/ | ||
Oxford, United Kingdom (UK) | Health and Medical +2 Health and Medical, Sport and Recreation, Science and Engineering | 50-100 | contact@ochre-bio.com | https://www.ochre-bio.com/ | ||
Oslo, Norway | Science and Engineering +1 Science and Engineering, Health and Medical | 30-50 | kvam@oncoinvent.com | https://www.oncoinvent.com/ | ||
Oxford, United Kingdom (UK) | Science and Engineering +1 Science and Engineering, Information Technology | 100-150 | hi@oni.bio | https://oni.bio/ | ||
Ghent, Belgium | Science and Engineering +3 Science and Engineering, Business Services, Information Technology, Health and Medical | 30-50 | hello@ontoforce.com | https://www.ontoforce.com/ | ||
London, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@opencell.bio | https://www.opencell.bio/ | ||
Oslo, Norway | Health and Medical +2 Health and Medical, Science and Engineering, Manufacturing and Industry | 150-200 | info@optinose.com | https://www.optinose.com/ | ||
London, United Kingdom (UK) | Manufacturing and Industry +2 Manufacturing and Industry, Science and Engineering, Health and Medical | 50-100 | info@oribiotech.com | https://oribiotech.com/ | ||
Barcelona, Spain | Health and Medical +2 Health and Medical, Sport and Recreation, Science and Engineering | 50-100 | info@oryzon.com | https://www.oryzon.com/en | ||
Lyon, France | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | contact@osivax.com | https://osivax.com/ | ||
Brussels, Belgium | Science and Engineering +3 Science and Engineering, Design Services, Health and Medical, Information Technology | 20-30 | info@ovizio.com | https://ovizio.com/ | ||
Oxford, United Kingdom (UK) | Health and Medical +1 Health and Medical, Science and Engineering | 1000-5000 | info@nanoporetech.com | https://nanoporetech.com/ | ||
Paris, France | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | contact@pathoquest.com | https://www.pathoquest.com/ | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 100-150 | info@biomodal.com | https://biomodal.com/ | ||
Birmingham, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@coppertreeforensics.co.uk | https://www.coppertreeforensics.co.uk/ | ||
Prague, Czechia | Health and Medical +1 Health and Medical, Science and Engineering | 150-200 | media@sotio.com | https://sotio.com/ | ||
The Hague, The Netherlands | Food and Beverages +3 Food and Beverages, Health and Medical, Manufacturing and Industry, Science and Engineering | 2-10 | invest@sibo.tech | https://sibo.tech/ | ||
Oxford, United Kingdom (UK) | Science and Engineering Science and Engineering | 50-100 | info@enarabio.com | https://enarabio.com/ | ||
Sheffield, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@unicornb.io | https://www.unicornb.io/ | ||
London, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | solutions@renewtech.co | http://www.renewtech.co | ||
Roma, Italy | Science and Engineering Science and Engineering | 2-10 | info@ghenesisbiotech.com | https://ghenesisbiotech.com/ |
50/764 results
Free Preview - Top 50 companies
Export Free JSON (50)
Frequently asked questions
FAQ updated November 2025
What is Enterprise League?
Enterprise League is a business platform built for the doers, small businesses and startups who want to get seen, get leads, and grow.We help you showcase your company, connect directly with potential clients and partners, and get valuable insights into your performance, all without the middlemen or the fluff. Whether you're a team of 2 or 200, Enterprise League puts you on equal ground with the big players.
How can my business benefit from joining Enterprise League?
You get visibility, leads, and control, all in one place. Joining Enterprise League puts your business in front of thousands of verified companies. List your services, connect with decision-makers, and see real-time data on who’s visiting your profile.It’s a streamlined way to grow your presence, build partnerships, and stop relying on outdated directories or cold outreach.
What are the key features of Enterprise League?
Enterprise League gives you tools to grow faster: • Custom Profiles:Boos your visibility with a standout business profile. • Smart search: Get found by clients looking for your exact services. • Real analytics: See who's visiting, what's working and where you rank. • Direct messaging: Skip the cold emails and chat direct with prospects. • Reviews insights: Showcase real reviews and let AI highlight what matters. • Zero-fee marketplace: List and find products or services for free.
How does the company verification process work?
Get verified for the price of a coffee $0 Verified companies appear higher in search, build trust faster, and unlock an extra features. One badge. More business.
Can I try Enterprise League for free?
Absolutely. Our Free Plan is built for small businesses. You get profile visibility, marketplace access, and business directory use, free. Want more reach and features? Upgrade when you’re ready. No pressure.
How does the Interactive Business Directory work?
It’s like Google, but only for serious businesses. Search by location, size, or sector. Visit company profiles, send a message, or download insights. It’s built for real B2B decisions, not noise.
How can I download business insights?
Need competitor or market data? We’ve got it, and yes, you can download it. With our Business Insights Download feature, you can export detailed company and industry data in CSV format, including decision-makers, background info, and more. It’s perfect for sales targeting, market research, or just getting smarter about your next move.
What is the Referral Program?
Invite a business friend. You both get rewarded. Refer another company and when they join, you both get 1 month of Premium — free. It’s our way of growing the community with good people.
How does the Reviews feature work?
Show off your best reviews, without lifting a finger. We pull your reviews from Google, Facebook, Trustpilot and more. Then our AI highlights the most important insights. You just sit back and shine.
What plans are available?
Three simple plans: Free Plan: Get started with a verified profile, search access, and marketplace listing. Premium: More reach, more leads, deeper analytics. Ultimate: All the bells and whistles, including a dedicated growth partner.
How can my company win an award?
We highlight the best of the best, and that could be you. We run 50+ startup award categories every year. Apply for free. Winners get recognition, visibility, and bragging rights.